Biogen, Inc. (NASDAQ/BGEN) today announced that Lawrence C. Best, Boston Scientific’s Senior Vice President and Chief Financial Officer, has been elected to the Biogen Board of Directors. The election took place at the company’s Board of Directors’ meeting on February 7, 2003.

Mr. Best has served as Senior Vice President and Chief Financial Officer for Boston Scientific since 1992. Prior to his work with Boston Scientific, Mr. Best was a partner in the accounting firm of Ernst & Young, where he specialized in serving multinational companies in the high technology and life sciences fields. He served a two-year fellowship at the Securities & Exchange Commission from 1979 to 1981 and a one-year term as a White House-appointed Presidential Exchange Executive in Washington, D.C.

James C. Mullen, Biogen’s Chairman and Chief Executive Officer, said, “Larry Best is a distinguished business leader whose expertise in corporate finance has helped Boston Scientific realize considerable growth. He is an outstanding addition to our Board of Directors as Biogen seeks to achieve continued operating success and pioneer new therapeutic advancements that help improve the quality of patients’ lives.”

About Biogen

Biogen is the world’s oldest independent biotechnology company and a leader in biologics research, development and manufacturing. A pioneer in leading edge research in immunology, neurobiology and oncology, Biogen brings novel therapies to improve patients’ lives around the world through its global marketing capabilities. For press releases and additional information about the company, please visit

Media Contact:
Amy Brockelman
Manager, Public Affairs
Biogen, Inc.
Tel: (617) 914-6524

Investment Community Contact:
Christina Dillon
Manager, Investor Relations
Biogen, Inc.
Tel: (617) 679-2812